AbbVie Proves Masterful at Playing Drug Patent Game
AbbVie uses dozens of patents to ward off competition for a pricey cancer medicine
AbbVie, already famous for its Humira strategy, forms another ‘patent wall’ around Imbruvica: report
501c3 confirmation.pdf
An Entrepreneur’s Quest To Fix Drug Patents And Save Lives
Covid-19 has exposed the limits of the pharmaceutical market model
No Vaccine in Sight
The U.S. government contributed research to a Gilead remdesivir patent — but didn’t get credit
Covid Seen as Tipping Point to Lower Drug Prices, Patent Sharing
Coronavirus puts Big Pharma’s IP regime to the test